Across TCGA pan-cancer cohorts, ZNF479 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ZNF479’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where ZNF479 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF479 is over-expressed in tumor.
LIHC are the cancer types where ZNF479 tumor–normal differential expression is most reproducible.